Cytochrome P450 monooxygenases are biocatalysts that hydroxylate or epoxidise a wide range of hydrophobic organic substrates. To date their technical application is limited to a small number of whole-cell biooxidations. The use of the isolated enzymes is believed to be impractical due to the low stability of this enzyme class, to the stochiometric need of the expensive cofactor NADPH, and due to the low solubility of most substrates in aqueous media. To overcome these problems we have investigated the application of a bacterial monooxygenase (mutants of CYP102A1) in a biphasic reaction system supported by cofactor recycling with NADP + -dependent formate dehydrogenase from Pseudomonas sp 101. Using this experimental setup, cyclohexane, octane and myristic acid were hydroxylated. To reduce the process costs a novel NADH-dependent double mutant of CYP102A1 was designed. For recycling of NADH during myristic acid hydroxylation in a biphasic system NAD + -dependent FDH was used.
Introduction
Cytochromes P450 belong to the heme-containing enzyme class of monooxygenases (EC 1.14.x.y). They are widely distributed in nature and play an important role in primary and secondary metabolism as well as in detoxification of xenobiotic compounds. [1] P450 enzymes catalyse the transfer of molecular oxygen to even non-activated aliphatic or aromatic XH-bonds (X: -C, -N, -S). Moreover, a remarkable number of P450 enzymes are capable of epoxidising C=C-double bonds. [2] Common to both reaction types is the incorporation of one atom of dioxygen into the substrate, while the other atom is reduced to water by electrons ultimately originating from the nicotinamide cofactors NAD(P)H. Electrons are transferred from NAD(P)H to the P450 heme iron via a flavin reductase or / and an iron-sulphur-protein. [3] Currently oxygenases are mainly applied in whole-cell biotransformations. [4, 5] Whole cells stabilise the complex enzyme systems with up to three individual proteins and simultaneously regenerate cofactors based on the cellular metabolism.
Disadvantages of whole-cell processes might be a further metabolism of products, toxicity of the educts or products to the cell, and the recovery of products from a complex fermentation broth. Considering these problems, the use of isolated oxygenases in enzyme reactors could be advantageous. [6] [7] [8] [9] Regarding the application of isolated P450 monooxygenases in fine chemical synthesis, enzymes from bacterial sources turned out as more suitable than those originating from plants, fungi or vertebrates: besides a much higher activity compared to eucaryotic enzymes, bacterial P450s exhibit in many cases higher stability. [10] P450 enzymes consisting of a heme domain fused to an FAD-and FMN-containing P450 reductase domain are -in contrast to the majority of P450s -"self-sufficient", i.e., they do not have to be supplied with additional redox partners (reductases) apart from NADPH. The best characterised fusion protein CYP102A1 (also called CYP102A1) from Bacillus megaterium has been intensively studied during the last two decades. [11, 12] This enzyme converts saturated-and unsaturated fatty acids with chain length of C12 to C22 with high activity (up to 4000 min -1 ) and partially also high stereoselectivity to their subterminally oxygenated derivatives. [13, 14] Recently cloning and characterisation of two further fusion enzymes from Bacillus subtilis, which exhibit high homology to CYP102A1, was reported. [15] [16] [17] While a large number of publications describing novel evolved CYP102A1 mutants with altered substrate specificity exist, [18] [19] [20] [21] [22] [23] [24] [25] [26] there are only very few reports dealing with the use of these biocatalysts in preparative organic synthesis. [7, 27] Beside strong doubts concerning the operational stability of the enzyme class, the high cost of the nicotinamide cofactor NADPH which has to be added in stochiometric or even higher amount (if uncoupling is taken into account) seems to make their in vitro application impractical.
Several possibilities exist to circumvent the stochiometric need for cofactors, for example, the use of peroxides (so-called shunt-pathway) [28] or cathodic reduction of the heme iron. [29] [30] [31] Reduction of the oxidised cofactor NAD(P) + during biotransformations can be performed electrochemically via mediators [32] or enzymatically. Dehydrogenases are currently utilised for cofactor recycling in various biocatalytic processes. [7, 33, 34] In a previous paper we reported a cofactor recycling system for CYP102A1 by mean of an NADP + -dependent formate dehydrogenase (FDH, EC 1.
2.1.2) from
Pseudomonas sp 101. It has been shown that both enzymes can be used for synthesis in combination. [34] Using this approach we have developed a process for oxidation of cyclohexane in a biphasic (cyclohexane / aqueous buffer) system. Industrial oxidation of cyclohexane is a process still open to improvements. Thus on one hand this reaction serves as a model reaction for activation of an inert hydrocarbon, on the other hand there might be interest in an alternative approach.
In order to proof the general applicability of CYP102A1 mutants in two-phase reaction systems, hydroxylation of octane and myristic acid was investigated.
Further reduction of the process costs was achieved by switching the cofactor specificity of CYP102A1 from NADPH to NADH. The advantage of NADH is its lower price and higher stability. [47] Besides that NAD + -dependent dehydrogenases are more abundant in nature than their NADP + -dependent analogues, opening the possibility to combine CYP102A1-catalysed reactions with a large variety of dehydrogenases.
Results and Discussion

Identification of CYP102A1 Mutants Hydroxylating Cyclohexane
A set of CYP102A1 mutants constructed by site-directed mutagenesis was screened NADPH consumption in presence of 470 µM cyclohexane was tracked for 3 minutes to yield values which are, in contrast to initial reaction rates, valid for extended periods of time.
Highest activity (56 eq eq -1 min -1 ) was detected for the CYP102A1 mutant R47L, Y51F. Both amino acid substitutions render the substrate access channel more hydrophobic causing easier access of cyclohexane to the active centre of the enzyme. [35] [36] [37] The mutant R47L, Y51F, F87V, L188Q with enlarged binding pocket [38] also showed rather high activity of 38 eq eq -1 min -1 , however not reaching the double mutant's activity.
Uncoupling of NADPH oxidation and substrate hydroxylation resulting in reduction of oxygen to hydrogen peroxide or water is an issue frequently encountered in monooxygenase chemistry. [39, 40] 
Kinetic Characterisation
Kinetic data for the purified mutant R47L, Y51F were determined by monitoring of cyclohexane-dependent NADPH-oxidation at a saturating concentration of the cofactor. Substrate binding to P450 usually causes a heme spin-state shift from low to high, which can be monitored as changes in P450 absorbance spectra ( Figure 3 ).
Cyclohexane binds to R47L, Y51F leading to an increase in the difference between the absorbance at 417 nm (trough) and that at 387 nm (peak). However, the maximum heme spin-state shift was not reached at a concentration of cyclohexane of 500 µM, corresponding to full saturation of the active centre in aqueous milieu.
The plot of absorption differences at ~387 nm and 417 nm versus cyclohexane concentration indicates exponential growth of the spectral changes in the concentration range limited by the solubility limit (small graph in Figure 3 ). While Tween enhanced activity of the monooxygenase by increasing the cyclohexane concentration, the stability of monooxygenase and / or dehydrogenase was negatively affected.
Biphasic Reaction System Cyclohexane / Aqueous Buffer
We investigated the optimal conditions for hydroxylation of cyclohexane by CYP102A1 in a biphasic reaction system ( Figure 4 ). In this system cyclohexane acts as substrate pool and simultaneously as organic solvent for extraction of the reaction product. Thus the catalytic system is retained in the aqueous phase while the product may continuously be isolated from the organic phase. The cofactor recycling system is based on a mutant of FDH from Pseudomonas sp which has been proven as highly stable in organic solvents. [8, 41] organic phase initially cyclohexane aqueous phase 50 mM KPi pH7. The stability of this dehydrogenase in a 1:1 mixture of FDH reaction buffer and cyclohexane under vigorous stirring was tested. FDH activity assays revealed a halflife of at least one day for this cofactor regenerating enzyme in the two-phase system.
The effect of different protein stabilisation agents -glycerol, bovine serum albumin (BSA), catalase, PEG-derivatives -was studied. Addition of 10 mg ml -1 BSA and 0.2 mg ml -1 (600 U ml -1 ) catalase from horse liver stabilised the monooxygenases in the biphasic emulsion and led to higher activity for extended periods of time, resulting in an increase in product yield (data not shown).
Concentration of cyclohexanol in the organic phase measured during the biotransformation indicates that mutant R47L, Y51F was active for at least four days (~ 100 h) when stabilised by addition of BSA and catalase ( Figure 5 ). Limitations in transfer of substrate from the organic to the aqueous phase decrease reaction rates, at least if phase transfer is slower than the rate of hydroxylation.
This was not the case here, as can be concluded from Figure 5 . The triple mutant displayed a lower reaction rate than the double mutant ( Figure 1 , 7 eq eq -1 min -1 compared to 56 eq eq -1 min -1 respectively) also showed lower cyclohexanol production in the biphasic reaction system. For the best mutant R47L, Y51F the total turnover number (ttn) was 9620. An increase in ttn to 10280 was achieved by changing the reaction vessel from a stirred flask at RT to a shaking flask vigorously shaken at 160 rpm and 18°C.
In a further experiment, the reaction system was scaled up to one litre reaction volume (1.3 µmol of CYP102A1 R47L, Y51F) under continuous aeration. The on-line monitoring of oxygen partial pressure and pH allow to control the reaction progress.
As protons are stochiometrically consumed during the reaction (Figure 4 ), the pH value increases. The pH was readjusted daily using 1 M KPi pH 6.0. The subsequent loss in activity can -apart from the decrease in product development -be concluded from the increase in oxygen partial pressure (oxygen consumption by the hydroxylation reaction breaks down) and from the slower increase in pH.
The total turnover number in this system reached 12850, yielding 1.67 g of cyclohexanol (16.7 mmol). The course of product development indicates that the monooxygenase was active for at least 100 h. During the first 53 h productivity of the system (12.62 mmol cyclohexanol) was higher than during the second half of the reaction. Space-time yield during the first 53 h of reaction time amounts 23.8 mg l -1 h -1 . This result can be exceeded to the limit posed by the rate of substrate transfer to the aqueous phase by applying higher concentrations of CYP102A1 and FDH.
Conversion of Octane and Myristic Acid
In order to demonstrate the general applicability of the biphasic system, octane and myristic acid -both substrates of CYP102A1 mutant A74G, F87V, L188Q with turnover rates of 1760 nmol(NADPH) nmol(P450) -1 min -1 [19] and 2100 nmol(NADPH) -1 nmol(P450) -1 min -1 , respectively -were also investigated.
Similar to the experiments with cyclohexane octane was used as substrate and as organic phase. GC/MS analysis revealed a product mixture consisting of 2-, 3-and 4-octanol as well as the corresponding octanones. Formation of octanones by CYP102A1 was previously reported. [20] A possible mechanism for the formation of the ketones is a second hydroxylation of the alcohol to generate a gem-diol which dehydrates to the corresponding ketone. Ketones might alternatively originate from vic-diols via Pinakol rearrangement. In any case double hydroxylation is a prerequisite for ketone formation. For calculation of total turnover numbers the GC/MS signals of all reaction products were calibrated for quantification using authentic standards of known concentration. For octane hydroxylation ttn of 2200 was measured.
For hydroxylation of myristic acid in the biphasic system, the substrate was dissolved in dodecane. In preliminary investigations dodecane was proven not to be a substrate of CYP102A1 A74G, F87V, L188Q. Fatty acid hydroxylation was performed under constant air bubbling. Total reaction volume was 8 ml consisting of 4 ml of the aqueous catalyst system and 4 ml 100 mM myristic acid (91 mg) in dodecane.
With myristic acid as a substrate for CYP102A1, usually a mixture of the subterminally hydroxylated products is obtained. [13, 14] In the two-phase system, however, additionally to the monohydroxylated products dihydroxylated myristic acid derivatives were produced. A hydroxylation of 12-hydroxy and 13-hydroxy myristic acid has previously been reported, even though with low reaction rate. [42] Totally 92.9 mg of myristic acid and derivatives were extracted. This amount of substance consisted of 41.4 mg of myristic acid (predominantly found in the dodecane-phase) and of 51.5 mg (55 %) of hydroxylated products less soluble in dodecane.
Hydroxylated products consisted of 48 % monohydroxy (ω-1 to ω-7) and 52 % dihydroxy myristic acid (mixture of 7 regioisomers). As stated in Table 2 this corresponds to ttns of 3300 for the P450 enzyme and 825 for the cofactor NADP + .
These results clearly indicate the applicability of the biphasic reaction system for conversion of different substrates of CYP102A1. In contrast to cyclohexane hydroxylation, in case of octane and myristic acid, the selectivity of the P450 biocatalysts remains to be improved.
Conversion of Myristic Acid by an NADH-dependent CYP102A1 Mutant
Multiple sequence alignment of NADPH-dependent cytochrome P450 reductases, which supply the P450 monooxygenases with electrons, revealed 5 highly conserved positions important for cofactor specificity. [48, 49] These positions in CYP102A1 are S965, R966, K972 and Y974, which bind the 2'-phosphate group of NADPH and W1046, the so-called gate-keeping amino acid, involved in electron transfer. Döhr et al. changed the cofactor specificity of the human P450 reductase from NADPH to NADH via substitution of the gate-keeping tryptophan to alanine. [49] The same effect was observed for the CYP102A1 mutant W1046A, that could accept were K M (NADH) = 12 µM, k cat (NADH) = 14601 min -1 . Thus the catalytic efficiency (k cat /K M ) of the CYP102A1 reductase in NADH-dependent cytochrome C reduction was improved 640-fold. Further details on reductase mutants will be described elsewhere.
[52] The CYP102A1 reductase double mutant R966D, W1046S was fused to the CYP102A1 A74G, F87V, L188Q monooxygenase domain.To proof applicability of this NADH-dependent CYP102A1 mutant in organic synthesis, oxidation of myristic acid was performed in the two-phase reaction system described above for the NADPH-dependent variant, except that NADP + -dependent FDH and NADP + were exchanged by NAD + -dependent FDH [46] and NAD + . Extraction of the reaction mixture and subsequent GC/MS analysis revealed 20 % conversion to hydroxylated products.
The hydroxy-and dihydroxy myristic acid products identified were the same as in the NADPH-driven reaction. Again, about 50 % of the products were identified as dihydroxy myristic acid derivatives. The lower yield of products (20 % compared to 55 % yield in the NADPH-dependent reaction) is most likely a result of the lower amount of P450 enzyme added to the reaction mixture (5 nmol compared to 100 nmol).
Though the NADPH-dependent myristic acid hydroxylation seems to be limited by the substrate's phase transfer rate, while the NADH-dependent reaction is limited by the amount of enzyme used. In conclusion activity and stability of NADH-and NADPHdependent CYP102A1 are comparable. In this experiment the ttn reached 30000, to the knowledge of the authors the highest value reported for a P450 monooxygenase to date (Table 2) . Further experiments on use of the NADH-dependent system in preparative organic synthesis are currently being performed. 
Conclusions
The exploitation of isolated P450 monooxygenases in biocatalysis is a field of ongoing research. However, until now it is not certain if the properties of these enzymes allow their in vitro use. Although a few reports concerning the use of oxygenases (for a compilation see [53] ) in synthetic applications do exist, bioengineering-related data are still scarce.
We thus investigated hydroxylation of substrates of CYP102A1 in a biphasic system.
In order to facilitate catalyst preparation cell extracts were used without further Our experiments (Table 2) can be compared to the first report of preparative in vitro use of a bacterial P450 monooxygenase by Falck et al. [7] This group reported a synthesis of 14,15-epoxyeicosatrienoic acid from arachidonic acid (500 mg, 1.64 mmol) using CYP102A1 F87V (600 U, 500 nmol) and glucose-6-phosphate dehydrogenase for NADPH recycling. Their attempt was to dissolve the hydrophobic substrate using a large volume of aqueous buffer. 0.74 mmol of product were obtained from 4 l reaction mixture, allowing calculation of a ttn of approximately 1500.
This demonstrates that the two-phase system, apart from advantages in reaction engineering, is a promising approach leading to a ttn of 12800 with cyclohexane and 30000 with myristic acid as substrate respectively. The total turnover number of the cofactor ranging from ~300 up to ~1300 is one of the highest reported to date for a preparative application of isolated oxygenases. The total turnover numbers for the biocatalyst exceed the value of up to 2867 reported for the asymmetric epoxidation of styrene by styrene monooxygenase (StyAB) in a two-phase dodecane / aqueous buffer system. [8] In this case for the cofactor NAD + a maximum turnover number of 87 was detrmined. Lutz et al. investigated the preparative application of 2-hydroxybiphenyl 3-monooxygenase with enzymatic cofactor regeneration. They reached a ttn for NAD + of maximally 503. [53] In cell-free application of cyclohexanone monooxygenase coupled to NADPH regeneration by alcohol dehydrogenase from
Thermoanaerobium brockii it was shown that conversion of 10 g l -1 bicyclo[3.2.0]hept-2-en-6-one is possible if the substrate is fed continuously. [54] While volumetric productivities reported here are quite low (maximum 0.15 g l -1 h -1 ), higher values found in literature (up to 1 g l -1 h -1 ) [8] are usually calculated for reaction times of 10 h or less compared to up to 100 h in our P450-mediated approach.Switching the cofactor specificity of CYP102A1 to NADH allows to reduce the cofactor costs to about 20%. Further investigations concerning the stability and general applicability of the NAD + -dependent reaction system are required.
Essentially the results reported here suggest that use of cytochromes P450 in enzyme reactors is an emerging and practical method in fine chemical synthesis. The current state of our investigations reveals the following bottlenecks:
i) Low solubility of the hydrophobic substrates in aqueous buffer solution resulting in low overall reaction velocity.
ii) Insufficient stability and -of particular importance with cyclohexane and octane as substrates -activity of the monooxygenase under process conditions.
iii) In reactions with octane and myristic acid product mixtures were obtained.
Further research in the field of catalyst design and reaction engineering is needed to optimise application of CYP102A1 in conversion of different substrates. In this context a detailed simulation of the processes under investigation will be advantageous.
Comparison with other cofactor-dependent oxygenases reveals that cytochrome P450-monooxygenases act as candidates if biocatalysts performing selective oxidations are in demand.
Experimental Section Chemicals, Enzymes and Strains
All chemical reagents were of analytical grade or higher and purchased from Fluka, Aldrich, Sigma or Riedel-de-Haën. NADPH tetrasodium salt and FDH from
Pseudomonas sp 101 were procured from Jülich Fine Chemicals (Jülich, Germany).
E. coli strain BL21 (DE3) and vector pET28a+ were obtained from Novagen (Madison, Wisconsin, USA).
Cyclohexane was distilled prior to use in order to remove traces of cyclohexanol and cyclohexanone.
Saturated solutions of substrates in aqueous buffer were prepared by adding 5 ml of organic substrate to 50 ml of 50 mM potassium phosphate buffer (Kpi), pH 7.5. The biphasic mixture was vigorously stirred over night, the substrate-saturated aqueous phase was separated using a separatory funnel and used immediately.
Design of NADH-dependent Reductase Mutants
For creation of an NADH-dependent mutant of CYP102A1 a sequence alignment with the rat cytochrome P450 reductase was performed and two positions important for cofactor specificity of CYP102A1 were identified. The corresponding mutants were constructed by site-directed mutagenesis using the Stratagene QuickChange™ Kit (Stratagene, La Jolla, Ca, USA) according to the manufacturer's protocol.
Mutations were introduced to plasmid pT-USC1BM3 [51] using the following Reductase activity was measured by standard cytochrome c reduction assay as described previously. [50] Expression and Purification of CYP102A1 Mutants
The expression system pET28a+CYP102A1 was described previously. [34] Mutations were introduced by PCR using the QuikChange TM site-directed mutagenesis kit from Stratagene according to the manufacturer's protocol. [43] High level protein expression was achieved using a slightly modified version of the protocol already published. [34] By incubating the starter culture for only 4 h, using terrific broth (TB)-medium for expression and prolonging cultivation time after induction to 16 h at 25°C, 800 to 1200 nmol (96 to 144 mg) of soluble CYP102A1 per litre of cell culture were obtained. Aliquots of the crude cell lysates containing 25 to 50 µM CYP102A1 were stored at -20°C or directly used for preparative reactions.
For kinetic measurements purified enzyme was used. Purification was performed according to a two-step strategy using a Ni-sepharose HP (Amersham Biosiences, Sweden) column with elution by 100 mM imidazole first. For further purification and to remove imidazole, the eluate was loaded onto a fractogel EMD DEAE 650S (Merck KgaA, Darmstadt, Germany) column and eluted by applying a linear sodium chloride gradient.
Activity Assays and Characterisation of Mutants
Substrate binding difference spectra, NADPH oxidation and CO-difference spectra were recorded on an Ultrospec 3000 UV/vis spectrometer (Amersham Biosciences, Sweden). Concentration of correctly folded P450 enzymes was determined from the CO-binding difference spectra of the reduced heme iron using an extinction coefficient of 91 mM -1 cm -1 as reported elsewhere. [44] For selection of mutants with activity towards cyclohexane 160 µl cyclohexane- Kinetic measurements were performed in sealed cuvettes at least in triplicates to reduce standard errors.
Coupling efficiency was measured by incubation of purified CYP102A1 (3 µM), 50 U ml -1 catalase with 0.4 mM cyclohexane and 0.2 mM NADPH in a sealed cuvette. After total consumption of NADPH the reaction mixture was extracted three times with 300 µl 1-butanol or diethyl ether. The combined organic layers were dried over MgSO 4 and analysed by quantitative GC/MS. From the amount of substrate converted, the coupling of NADPH oxidation to product formation can be deduced.
Substrate binding difference spectra were recorded using standard procedures. [13, 45] Myristic acid was oxidised in aqueous buffer by adding 20 µl of 5 mM myristic acid dissolved in DMSO to 930 µl of 1 µM CYP102A1 in 50 mM KPi, pH7.5. The reaction was started by addition of 50 µl 10 mM NADPH in 50 mM KPi, pH7.5. After 15 min the reaction mixture was acidified using dilute HCl and extracted thrice with diethyl ether and analysed as described in section product identification.
FDH activity assays were performed to estimate the stability of FDH when stirred with cyclohexane. The same assay was used during reactions to measure residual FDH activity. The assay was performed by adding 50 µl FDH-containing solution to a cuvette containing 950 µl FDH reaction buffer (50 mM KPi, 300 mM Na + HCOO -, 0.1 mM NADP + , pH 7.0) and measuring NADPH development at 340 nm.
Preparative Incubation in Biphasic Systems
The aqueous phase consisted of 250 mM sodium formate, 50 mM KPi, 10 mg ml 
